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Abstract
Introduction:  Procedures  for  extending  the  life  of  newborns  are  closely  related  to  potential
causes of  hearing  loss,  justifying  the  identiﬁcation  and  understanding  of  risk  factors  for  this
deﬁciency.
Objective: To  characterize  the  population,  analyze  the  frequency  of  risk  factors  for  hearing
loss, and  assess  the  audiological  status  of  infants  attended  in  a  Newborn  Hearing  Screening
program (NHS).
Methods:  This  was  a  retrospective  study  that  analyzed  medical  records  of  140  patients  from
a neonatal  intensive  care  unit,  identifying  the  frequency  of  risk  factors  for  hearing  loss  and
audiological  status,  utilizing  transient  otoacoustic  emissions  and  brainstem  auditory  evoked
potential (BAEP).
Results:  Prematurity  was  present  in  78.87%  of  cases;  45%  of  the  infants  were  underweight  and
73% received  ototoxic  medication.  Audiologically,  11.42%  failed  the  NHS,  and  5%  of  cases  failed
retest; of  these,  one  had  results  compatible  with  hearing  loss  on  BAEP.
Conclusion:  A  higher  rate  of  low  birth  weight,  and  prematurity  was  observed  in  infants  who
underwent screening  and  had  an  audiological  diagnosis  by  the  third  month  of  life.  Only  one
newborn presented  a  change  in  audiological  status.  The  authors  emphasize  the  importance  of
auditory monitoring  for  all  infants,  considering  this  as  a  high-risk  sample  for  hearing  loss.
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Resumo
Introduc¸ão:  Os  procedimentos  para  prolongamento  da  vida  dos  neonatos  estão  intimamente
relacionados  com  possíveis  causas  de  deﬁciência  auditiva,  justiﬁcando-se  a  identiﬁcac¸ão  e  o
conhecimento  dos  indicadores  de  risco  para  tal  deﬁciência.
Objetivo:  Caracterizar  a  populac¸ão,  analisar  a  frequência  dos  indicadores  de  risco  para  a  deﬁ-
ciência auditiva  e  veriﬁcar  o  status  audiológico  de  bebês  atendidos  num  programa  de  Triagem
Auditiva Neonatal  (TAN).
Método:  Estudo  do  tipo  retrospectivo.  Foram  analisados  140  prontuários  da  Unidade  de  Terapia
Intensiva  Neonatal,  caracterizando  a  populac¸ão  estudada  e  a  frequência  dos  indicadores  de
risco para  deﬁciência  auditiva  e  status  audiológico,  e  considerando  resultados  das  emissões
otoacústicas  transientes  e  a  avaliac¸ão  diagnóstica  por  meio  do  Potencial  Evocado  Auditivo  de
Tronco Encefálico  (PEATE).
Resultados:  Evidenciou-se  prematuridade  em  78,87%  dos  casos,  45%  exibiam  baixo  peso  e  73%
estavam sendo  medicados  com  agentes  ototóxicos.  Quanto  ao  status  audiológico,  11,42%  fal-
haram na  TAN.  Houve  falha  no  reteste  em  5%  dos  casos  e,  destes,  um  neonato  apresentou
resultado  compatível  com  deﬁciência  auditiva  no  PEATE.
Conclusão:  Houve  maior  porcentual  de  prematuros  de  baixo  peso  que  realizaram  a  triagem
e tiveram  um  diagnóstico  audiológico  até  o  3◦ mês  de  vida.  Apenas  um  neonato  apresentou
status audiológico  alterado.  Ressalta-se  a  importância  de  acompanhamento  auditivo  de  todos
os bebês,  considerando  esta  amostra  como  de  alto  risco  para  deﬁciência  auditiva.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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The  detection  of  speech  sounds  begins  in  intrauterine
life,  and  is  the  ﬁrst  step  in  language  acquisition,  since
it  is  known  that  hearing  and  language  are  interdepen-
dent  but  interrelated  functions.  Auditory  experiences  are
of  paramount  importance,  especially  before  the  second
year  of  life,  as  this  is  considered  the  critical  period  for
language  acquisition.1--3 Thus,  infants  who  are  born  with
hearing  impairment  (HI),  are  deprived  of  contact  with  the
world  of  sound.  In  this  way,  the  right  time  for  the  detec-
tion/diagnosis  of  childhood  HI  is  before  the  third  month
of  life,  and  the  intervention  should  begin  before  the  sixth
month.1,4,5
Studies  show  that  the  incidence  of  signiﬁcant  bilateral
congenital  HI  in  healthy  neonates  is  about  1--3  infants/
1000  births;  conversely,  in  newborns  referred  from  intensive
care  units  the  incidence  increases  to  2--4%.5
There  are  prenatal,  perinatal,  and  postnatal
complications  that  can  cause  HI  in  newborns;  these
are  called  risk  factors  associated  with  hearing  loss  (RFHL),
namely:  the  concern  of  parents  with  respect  to  their  child
general  development  and  the  child’s  hearing,  speech,
or  language  development;  familial  history  of  permanent
deafness;  neonatal  intensive  care  unit  (NICU)  stay  >5  days;
or  occurrence  of  any  associated  condition,  such  as  the
use  of  ototoxic  medication;  congenital  infections  (rubella,
cytomegalovirus,  syphilis,  herpes,  and  toxoplasmosis);
craniofacial  anomalies;  genetic  syndromes;  neurodegener-
ative  disorders;  postnatal  bacterial  or  viral  infections;  head
trauma;  and  chemotherapy.4
f
h
iHospitalization  in  NICUs  is  a  very  frequent  risk  factor.
reterm  infants  are  generally  underweight,  in  need  for
engthy  mechanical  ventilation,  and  may  have  hyperbiliru-
inemia  at  levels  that  require  exchange  transfusion,  thus
aking  a  NICU  stay  imperative.6
The  Newborn  Hearing  Screening  (NHS)  test  is  a  safe
nd  appropriate  procedure  for  the  early  detection  of  HI  in
eonates  and  infants.7 The  current  protocol  designates  as
 NHS  procedure  the  recording  and  analysis  of  transient-
voked  otoacoustic  emissions  (TEOAE)  for  neonates  without
FHL,  and  an  automatic  brainstem  auditory  evoked  poten-
ial  (aBAEP)  study  for  those  who  have  any  RFHL.4,5
TEOAE  recording  is  a relatively  simple,  quick,  and  objec-
ive  method  for  detecting  hearing  changes  of  cochlear
rigin,  speciﬁcally  from  the  outer  hair  cells.  This  method
oes  not  quantify  the  HI,  but  detects  the  presence  of  a
ochlear  dysfunction.8--10 BAEP,  which  is  also  an  objective
ethod,  is  obtained  with  surface  electrodes  that  record
eural  activity  generated  by  the  cochlea,  auditory  nerve,
nd  brainstem  in  response  to  auditory  stimuli.5,10
The  NHS  outcome  criterion  is  that  of  ‘‘pass  and  fail’’.
he  ‘‘pass’’  criterion  expresses  the  non-likelihood  of  HI,  and
he  ‘‘fail’’  criterion  expresses  the  likelihood  of  HI  and  the
eed  for  a  diagnostic  evaluation.  In  case  of  failure,  it  is  rec-
mmended  to  utilize  the  BAEP  diagnostic  procedure  for  an
nvestigation  of  electrophysiological  thresholds  before  hos-
ital  discharge  and/or  on  the  infant’s  return  for  retest.  If
he  HI  is  not  conﬁrmed,  these  infants  with  RFHL  should  be
ollowed-up,  as  they  are  at  an  increased  risk  of  difﬁculties  in
earing  and  in  language  skill  development.  If  an  alteration
n  BAEP  responses  is  detected,  the  child  will  be  referred
7 Rechia  IC  et  al.
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Table  1  Frequency  of  risk  factors  for  hearing  loss  (RFHL)
associated  with  hospitalization  in  a  neonatal  intensive  care
unit.
RFHL  Frequency
Family  history 5  (3.6%)a
Ototoxic  medication  103  (73%)a
Mechanical  ventilation  81  (57.9%)a
Hyperbilirubinemia  19  (13.6%)a
Congenital  infections  3  (2.1%)a
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t  once  for  a  medical  otolaryngological  diagnosis  and  a full
udiological  evaluation  for  early  rehabilitation.4
This  study  was  undertaken  because  of  a  need  to  identify
nd  understand  RFHLs;  because  the  increase/advancement
f  technology  associated  with  the  procedures  that  seek  to
xtend  the  lives  of  newborns  and  infants  is  closely  related
o  the  very  factors  that  can  cause  hearing  impairment.
Thus,  this  study  aimed  to  characterize  the  population,
nalyze  the  frequency  of  RFHL,  and  assess  the  audiological
tatus  of  infants  treated  in  an  NHS  program  referred  from
he  NICU  of  a  university  hospital.
ethods
his  research  is  linked  to  a  larger  project,  called  ‘‘Child
earing  Impairment:  from  diagnosis  to  intervention,’’  which
as  approved  by  the  Research  Ethics  Committee  under  No.
10,506.
This  was  a  retrospective  study,11 that  aimed  to  investi-
ate  issues  related  to  hearing  health  in  infants  referred  from
he  NICU.
The  sample  analyzed  medical  records  of  newborns  (NB)
nd  infants  who  underwent  NHS  and  who  came  from  the
ICU  during  the  period  from  September  of  2012  to  May  of
013  in  a  university  hospital.
The  sample  arrangement  was  made  on  the  basis  of  eli-
ibility  criteria.  The  inclusion  criteria  for  the  analysis  of
linical  records  were  as  follows:  the  baby  should  have  been
orn  and  remained  in  the  NICU  for  at  least  ﬁve  days,  with  an
HS  carried  out  in  this  service.  Clinical  records  with  incom-
lete  information  and  those  without  an  informed  consent
igned  by  the  parent  or  guardian  were  excluded  from  data
ollection.  This  NHS  service  provides  an  informed  consent
xplaining  to  those  legally  responsible  for  the  child  that  the
ata  collected  on  this  service  may  be  used  for  future  studies,
nd  that  all  ethical  issues  involved  will  be  upheld;  nonethe-
ess,  the  informed  consent  must  be  signed  at  the  time  of
heir  child  care.
Based  on  a  review  of  medical  records,  2097  consulta-
ions  were  retrieved  in  that  period.  From  this  total,  140
edical  records  were  selected,  using  the  inclusion  crite-
ia.  The  following  variables  were  recorded:  characteristics
f  study  population  (gestational  age  [GA],  birth  weight,  age
t  NHS);  frequency  of  RFHLs;  audiological  status,  based  on
he  results  documented  in  the  medical  record,  on  an  anal-
sis  of  TEOAE,  and  on  a  diagnostic  assessment  carried  out
ith  the  use  of  BAEP;  false-positive  rate;  and  prevalence
f  HI.  Such  data  (presence  of  RFHL,  and  TEOAE  and  BAEP
esults)  were  organized  into  categories  of  responses,  which
ere  stored  in  a  spreadsheet  in  Microsoft  Excel.  In  the  next
hase,  a  data  analysis  was  held  with  the  use  of  the  pro-
ram  PASW  Statistic  v.18.0  for  Windows.  In  the  descriptive
nalysis,  absolute  numbers  and  frequencies  of  respective
ariables  were  sought.  For  a  comparative  analysis  of  the  dis-
ribution  of  frequencies,  Fisher’s  exact  test  and  Cochran’s
est  (when  three  or  more  categories  were  present)  were
sed.  For  all  hypothesis  tests,  a  signiﬁcance  level  of  0.05
as  set.  Signiﬁcant  values  were  marked  with  an  asterisk.
ll  conﬁdence  intervals  determined  during  this  study  were
stablished  with  95%  of  statistical  conﬁdence.
t
t
pa Descriptive analysis.
esults
 total  of  140  medical  records  of  infants  with  NICU  stay  and
ith  mean  GA  of  34.76  (range:  22--42)  weeks  were  eval-
ated.  Of  these,  78.57%  (n  =  110)  were  preterm  newborns
ith  GA  <37  weeks;  20.71%  (n  =  29)  were  term  newborns
ith  GA  of  37--41  weeks  and  6  days;  and  0.72%  (n  =  1)  was
 post-term  newborn  with  GA  ≥42  weeks.  When  the  three
ategories  were  compared,  a  predominance  of  preterm  new-
orns  (p  <  0.001;  Cochran’s  test)  was  observed.
The  mean  birth  weight  of  these  infants  was  2299  g
630--4620).  Of  these,  39.28%  (n  =  55)  had  normal  weight,
hat  is,  ≥2501  g;  45%  (n  = 63)  had  low-birth  weight
1501--2500  g);  12.14%  (n  =  17)  had  very  low  birth
eight  (1001--1500  g);  1.43%  (n  =  2)  had  extremely
ow  birth  weight  (751--1000  g);  and  2.15%  (n  =  3)  were
mmature  infants  with  <750  g.
The  mean  age  at  NHS  was  66.06  days  (range:  5--492  days).
f  these,  77.85%  (n  =  109)  underwent  screening  before  the
hird  month  of  life;  and  22.15%  (n  =  31)  were  tested  after
he  third  month  of  life.  Thus,  a  statistically  signiﬁcant
ifference  between  these  two  groups  (p  <  0.001;  Fisher’s
est)  was  demonstrated.  Due  to  the  tenuous  health  sta-
us  of  some  newborns,  NHS  was  conducted  only  when
heir  clinical  condition  became  stable.  Thus,  some  chil-
ren  underwent  auditory  screening  in  a  post-neonatal  stage
eriod.
Regarding  NHS  outcome  and  characterization  of  audio-
ogical  status,  11.42%  (n  =  16)  infants  failed  the  ﬁrst  stage
f  the  NHS  program  carried  through  TEOAE.  Of  these
6  babies,  56.25%  (n  =  9)  passed  the  retest,  also  con-
ucted  by  TEOAE,  and  43.75%  (n  =  7)  failed  the  NHS
etest,  and  were  referred  for  BAEP.  Of  these,  85.71%
n  = 6)  showed  results  consistent  with  normal  hear-
ng,  and  only  14.29%  (n  =  1)  showed  results  compatible
ith  HI.  This  infant  was  referred  for  further  medical
xamination  and  subsequent  speech  therapy,  including
he  ﬁtting  of  hearing  aids.  Thus,  the  false-positive
ate,  that  is,  the  percentage  of  infants  that  failed
n  NHS,  but  who  had  normal  hearing,  was  10.71%
n  = 15).
The  prevalence  of  pediatric  HI  in  the  present  study  was
pproximately  0.71:100.  Table  1  shows  the  distribution  of
requencies  of  RFHL  in  this  sample.  It  is  worth  noting  that
hat  some  infants  had  more  than  one  RFHL.
Table  2  lists  the  results  obtained  in  the  ﬁrst  stage  of
he  NHS  program  and  in  NHS  retest,  according  to  the  RFHL
resented.
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Table  2  Risk  factors  for  hearing  loss  (RFHL)  and  audiological  status.
NHS  NHS  retest
RFHL  Passed  (n  =  124)  Failed  (n  =  16)  p-Valuea Passed  (n  =  9)  Failed  (n  =  7)  p-Valuea
Ototoxic  medication
Absent  34  (27.4%) 3(18.7%) 2  (22.2%) 1  (14.3%)
Present 90 (72.6%) 13  (81.3%) 0.560 7  (77.8%) 6  (85.7%) 1.00
Mechanical ventilation
Absent  52  (41.9%)  7  (43.7%)  5  (55.6%)  2  (28.6)
Present 72  (58.1%)  9  (56.3%)  1.00  4(44.4%)  5  (71.4%)  0.358
Hyperbilirubinemia
Absent 110  (88.7%)  11  (68.7%)  9  (100%)  2  (28.6%)
Present 14  (11.3%)  5  (31.3%)  0.044a 0  (0%)  5  (71.4%)  0.005a
Congenital  infection
Absent  121  (97.6%)  16  (100%)  --  --
Present 3  (2.4%)  0  (0%)  1.00  --  --
Family history
Absent  119  (96.0%)  16  (100%)  --  --
Present 5  (4.0%)  0  (0%)  1.00  --  --
Drugs/alcohol/smoking
Absent 106  (85.5%)  15  (93.7%)  9  (100%)  6  (85.7%)
Present 18  (14.5%)  1  (6.3%)  0.697  0  (0%)  1  (14.3%)  0.438
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a Statistically signiﬁcant values (p < 0.05); Fischer’s exact test.
Discussion
Prematurity  is  not  classiﬁed  as  a  RFHL  by  itself,  but  rather
due  to  the  special  care  in  the  NICU  that  these  patients
generally  require,  such  as  the  use  of  ototoxic  medication,
mechanical  ventilation,  and  specialized  consultations.12
A  recently  published  study  showed  that  GA  and  NICU  stay
at  birth  are  important  variables  related  to  the  likelihood  of
hearing  screening  failure,  and  that  there  is  a  prevalence
of  HI  in  preterm  newborns.  Moreover,  in  infants  with  a  con-
ﬁrmed  HI,  the  mean  GA  was  31  weeks.13 As  for  GA,  another
study  also  found  that  the  majority  of  these  patients  were
preterm.14 These  ﬁndings  make  it  possible  to  infer  that,
in  general,  the  NICU  population  consists  of  underweight
preterm  newborns  in  need  of  specialized  care.  This  study’s
data  agree  with  these  previous  studies,12--14 considering  that
most  of  this  sample  consisted  of  preterm  newborns.
Low  birth  weight  is  another  factor  for  alterations  in
child  development  among  primary  neonatal  high-risk  fac-
tors.  This  study  assessed  the  birth  weight  of  newborns  and
infants  treated  at  the  NICU.  The  mean  birth  weight  was
2299  g  (630--4620)  g;  45%  (n  =  63)  of  the  sample  had  low-birth
weight  (1501--2500  g).  Similarly,  another  study  conducted
with  a  sample  of  71  newborns  found  that,  of  this  total,
52.1%  (n  =  37)  had  a  low  weight  birth,15 which  agrees  with
the  present  ﬁndings.
Regarding  the  time  for  diagnosis  of  HI  in  NBs,  it  is  a  gen-
eral  consensus  that  such  diagnosis  should  be  established
early.5 It  is  known  that  a  child  with  a  diagnosis  of  HI  who
starts  speech  therapy  before  6  months  of  life  is  more  likely
to  develop  a  proper  hearing,  and  also  a  better  oral  language
(with  statistical  signiﬁcance),  when  compared  to  children
s
a
siagnosed  later.1 In  the  present  study,  the  mean  age  at
HS  was  66.06  (5--492)  days;  77.15%  (n  =  109)  of  the  sam-
le  were  submitted  to  this  screening  before  the  third  month
f  life.  Babies  who  failed  the  ﬁrst  stage  of  NHS  program  were
eferred  for  retesting,  with  an  audiological  diagnosis  before
ompletion  of  the  third  month  of  life,  which  is  in  accordance
ith  national  and  international  recommendations  regarding
he  time  of  diagnosis.1,4,5
Regarding  the  outcome  of  NHS  and  characterization  of
udiological  status,  11.42%  (n  =  16)  of  the  sample  failed  the
rst  stage  of  the  NHS  program  conducted  through  TEOAE.  Of
hese,  43.75%  (n  =  7)  failed  a  retest.  Infants  who  failed  the
etest  were  referred  for  diagnosis  and  only  14.29%  (n  =  1)
howed  results  compatible  with  HI.  This  ﬁnding  emphasizes
he  false-positive  rate  of  the  NHS  program.
It  is  recommended  that  the  false-positive  rate  not  exceed
%.4,16 In  this  university  hospital,  the  false-positive  rate  was
0.71%  (n  =  15).  This  high  rate  can  be  explained  by  factors
uch  as  excessive  background  noise,  since  the  room  where
he  NHS  is  performed  does  not  have  sound  insulation;  and
he  performance  of  NHS  by  an  inexperienced  staff  (as  this
s  a  teaching  hospital,  where  students  perform  their  prac-
ical  activities  and  are  in  a  process  of  construction  of  their
linical  practice).  Also,  the  use  of  TEOAE  as  the  NHS  pro-
edure  could  have  had  an  effect  since,  although  BAEP  is
he  procedure  speciﬁed  for  infants  with  RFHL,4 that  equip-
ent  was  not  available  for  carrying  out  this  procedure.  The
ospital  has  since  purchased  this  equipment  for  use  by  NHS
ervice,  thus  allowing  for  NHS  in  accordance  with  national
nd  international  standards.4,5
The  ﬁndings  of  the  present  study  are  similar  to  another
tudy  that  reported  a  false  positive  rate  of  24.41%,17 well
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bove  the  internationally  recommended  level.18 However,
hey  are  in  disagreement  with  the  ﬁndings  of  another  Brazil-
an  study,  that  reported  a  false  positive  rate  of  only  1%,19
ithin  the  target  established  in  the  literature.  Their  rate
as  possibly  achieved  by  the  presence  of  an  otolaryngology
ervice  in  that  hospital’s  NHS  program,  by  the  use  of  a  facili-
ator  auricular  maneuver,  and  by  the  fact  that  the  procedure
as  performed  by  highly  specialized  speech  therapists.
In  the  present  study,  the  prevalence  of  HI  was  0.71:100
ive  births.  Another  Brazilian  study  found  a  prevalence  of
.138:100  live  births  for  HI.19 Conversely,  studies  in  foreign
anguages  found  a  prevalence  of  2--4%  for  HI  in  newborns
eferred  from  NICUs.5
It  is  not  possible  to  make  inferences  regarding  this  dif-
erence,  but  it  is  believed  that  further  studies  with  larger
amples  would  elucidate  more  precisely  the  issues  related
o  the  occurrence  of  HI  in  babies  referred  from  NICUs.
Table  1  shows  that  the  most  prevalent  of  all  risk  factors
as  ototoxic  medication  (73%),  which  may  harm  and  damage
he  cochlear  function,  leading  to  HI.20 The  present  results
ere  similar  to  those  found  in  other  studies,  in  which  the
ost  frequent  risk  factor  in  the  populations  studied  was
he  use  of  ototoxic  drugs.21,22
Due  to  their  health  conditions,  many  newborns  need  NICU
ospitalization  and  mechanical  ventilation.  Several  aspects
ave  been  linked  to  higher  rates  of  deafness  in  children
ubmitted  to  assisted  ventilation,  including  the  noise  level
f  the  machine,  duration  of  mechanical  ventilation,  and
he  lung  diseases  involved.23 In  the  present  study,  57.9%
n  =  81)  of  the  infants  required  mechanical  ventilation.  Of
hese,  88.9%  (n  =  72)  achieved  a  passing  result,  and  only
1.1%  (n  =  9)  failed  the  initial  NHS.  These  results  are  con-
istent  with  another  study  of  200  newborns,  in  which  there
as  a  high  prevalence  of  mechanical  ventilation.  Of  these,
4.5%  (n  =  169)  achieved  a  passing  result,  and  15.5%  (n  =  31)
ailed  the  NHS.23 Likewise,  hyperbilirubinemia  has  a  toxic
ffect  on  cochlear  hair  cells,  basal  nuclei,  and  central  audi-
ory  pathways.24 In  the  present  study,  13.6%  (n  =  19)  of
he  sample  had  hyperbilirubinemia.  A  study  with  a sam-
le  of  2002  newborns  found  that  3.9%  of  this  population
ad  some  RFHL.  Among  these,  24.1%  had  hyperbilirubine-
ia  and  3.9%  required  mechanical  ventilation  for  over  ﬁve
ays.25
In  Table  2,  the  authors  sought  to  examine  the  association
etween  the  NHS  result  in  the  ﬁrst  stage  of  the  program,  and
n  NHS  retest,  considering  the  RFHLs  found  in  this  sample.  In
he  ﬁrst  stage  of  the  evaluation,  carried  out  through  TEOAE,
1.3%  (n  =  13)  of  the  sample  in  use  of  ototoxic  medication
ailed  the  NHS.  This  ﬁnding  is  in  agreement  with  another
tudy,  in  which  8.6%  of  the  infants  who  failed  NHS  had  some
FHL,  and  of  these,  the  most  prevalent  factor  was  the  use
f  ototoxic  medication  (42.9%).25
Studies  show  that  babies  who  received  exchange  transfu-
ion  due  to  high  rates  of  bilirubin  may  fail  the  NHS.25,26 The
tructures  of  the  auditory  system  show  high  sensitivity  to
he  toxic  effects  of  bilirubin.  Among  the  hearing  problems
aused  by  the  effects  of  hyperbilirubinemia,  auditory  neu-
opathy,  which  may  (or  not)  be  associated  with  other  hearing
isorders,  is  noteworthy.27 In  contrast,  in  the  present  study,
hildren  who  presented  such  RFHL  had  normal  hearing,  in
ccordance  with  other  studies  that  observed  no  changes  in
uditory  pathways  in  newborns  with  hyperbilirubinemia.28,29Rechia  IC  et  al.
Considering  this  study  sample,  it  was  found  that
mong  the  RFHLs  associated  with  NICU,  congenital  infec-
ion  had  the  lowest  occurrence  (2.14%).  All  subjects  with
his  RFHL  achieved  a  passing  result  in  NHS.  However,  studies
how  that,  even  when  asymptomatic,  congenital  infections
rubella,  syphilis,  cytomegalovirus,  herpes,  toxoplasmosis,
nd  acquired  immunodeﬁciency  syndrome)  can  cause  HI  in
he  neonate  and  may  be  associated  with  late-onset  HI  and/or
ith  progression  of  some  HI  already  present  at  birth.30,31
onclusion
f  the  140  patients  screened  during  the  study  period,  there
as  higher  incidence  of  preterm  newborns  with  low  birth
eight  and  of  NHS  and  audiological  diagnosis  performed
efore  the  third  month  of  life.  The  most  frequent  risk  fac-
or  was  use  of  ototoxic  medication,  which  is  often  associated
ith  mechanical  ventilation;  both  were  present  in  the  single
ewborn  who  presented  an  audiological  assessment  consis-
ent  with  HI.  However,  in  spite  of  an  association  between
yperbilirubinemia  and  ‘‘failed’’  results  in  tests  and  retests,
AEP  results  consistent  with  normal  hearing  were  noted  for
ll  subjects  with  such  RFHL.
Taking  into  account  that  this  study  sample  was  considered
o  be  at  high  risk  for  HI,  the  authors  must  emphasize  the
mportance  of  auditory  monitoring  until  the  third  year  of  life
f  the  child,  during  which  hearing  changes  of  progressive-  or
ate-onset  character  may  be  identiﬁed.
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